financetom
Business
financetom
/
Business
/
Newell Brands Shares Surge On Strong Q2 Earnings Beat And Upgraded FY24 Outlook Despite Revenue Dip
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Newell Brands Shares Surge On Strong Q2 Earnings Beat And Upgraded FY24 Outlook Despite Revenue Dip
Jul 26, 2024 7:12 AM

Newell Brands Inc. ( NWL ) shares are trading higher, fueled by better-than-expected second-quarter earnings and a raised FY24 outlook.

The company reported adjusted earnings per share of 36 cents, beating the analyst consensus of 21 cents.

Second quarter net sales were $2.03 billion, a 7.8% decline from the prior year period. Sales missed the street view of $2.046 billion.

Core sales declined 4.2% compared with the prior year period. Gross margin increased to 34.4% compared with 28.5% in the prior year period. Normalized gross margin increased to 34.8% compared with 29.9% in the prior year period.

Also Read: Walgreens Mulls Bond Sale As JPMorgan Gauges Investor Appetite: Report

Net interest expense was $78 million compared with $76 million in the prior year period.

At the end of the second quarter, Newell Brands ( NWL ) had debt outstanding of $5.0 billion and cash and cash equivalents of $382 million, compared with $5.4 billion and $317 million, respectively, at the end of the second quarter of 2023.

Chris Peterson, Newell Brands President and Chief Executive Officer, said, “We are making significant progress in driving Newell’s turnaround… We remain laser focused on returning the business to sustainable and profitable growth and are confident that we are pursuing the right strategy to accomplish this.”

Outlook: Newell Brands ( NWL ) has raised its FY24 outlook, now projecting adjusted EPS of $0.60-$0.65, up from $0.52-$0.62, compared to an estimate of $0.60, with a revenue decline of 7%-6% from a prior forecast of 8%-5%, versus a $7.63 billion estimate.

Newell Brands’ third quarter outlook projects adjusted EPS of $0.14-$0.17, below the $0.20 estimate, with revenue expected to decline by 6%-4%.

Mark Erceg, Newell Brands ( NWL ) Chief Financial Officer, said, “While the macroeconomic environment remains choppy, the transformation of our business is clearly underway, which has given us confidence to improve our financial outlook for the year.”

Price Action: NWL shares are trading higher by 27.1% to $8.06 at last check Friday.

Read Next:

US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mohawk Industries' Fiscal Q1 Adjusted Earnings Increase, Net Sales Slip
Mohawk Industries' Fiscal Q1 Adjusted Earnings Increase, Net Sales Slip
Apr 26, 2024
04:53 AM EDT, 04/26/2024 (MT Newswires) -- Mohawk Industries ( MHK ) reported fiscal Q1 adjusted earnings late Thursday of $1.86 per diluted share, up from $1.75 a year earlier. Analysts polled by Capital IQ expected $1.68. Net sales for the quarter ended March 30 were $2.68 billion, compared with $2.81 billion a year earlier. Analysts polled by Capital IQ...
China's CITIC Securities posts 8.5% fall in first-quarter profit
China's CITIC Securities posts 8.5% fall in first-quarter profit
Apr 26, 2024
BEIJING/SHANGHAI(Reuters) - CITIC Securities Co, China's biggest brokerage, on Friday reported an 8.5% fall in first-quarter net profit. Net profit fell to 4.96 billion yuan ($684.47 million) in the three months to March 31, compared with 5.42 billion yuan in the same period last year, the company said in a stock exchange filing. ($1 = 7.2465 Chinese yuan renminbi) ...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Apr 26, 2024
(Reuters) - Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to eligible patients in the U.S. using its specialty pharmacy beginning in June, the health insurer said on Thursday. Cigna said it will stock high- and low-concentration biosimilar versions of Humira from drugmakers including Boehringer Ingelheim, Teva and Alvotech at its...
US regulator pauses plans to scrutinize asset manager stakes in banks
US regulator pauses plans to scrutinize asset manager stakes in banks
Apr 26, 2024
WASHINGTON (Reuters) -A top U.S. bank regulator on Thursday shelved a vote to impose stricter oversight on asset managers like BlackRock and Vanguard that have big passive stakes in banks, despite officials agreeing the matter merited more attention. The Federal Deposit Insurance Corporation postponed votes on two competing plans that would have given the agency more power to scrutinize asset...
Copyright 2023-2026 - www.financetom.com All Rights Reserved